30 April 2020

Safety Alerts and Recalls Medical Devices & Pharmaceutical Products

Reference: CIR-2020-00000127

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

• Pharmaceutical product Recall Esmya (Ulipristal acetate) 5mg Tablet 
• Recall one Batch of pharmaceutical product Dopamine HCL 200mg5ml ampoule
• Fraudulent Coronavirus tests, Vaccines _ Treatments Teas, essential oils, tinctures and colloidal silver
• Medical Device Alerts Anesthesia devices
• Recall, Suspension of registration and stop Importation of all Ranitidine drugs

 

Thanks in advance for your good co-operation

Drug Control Section

Health Regulation Sector

DHA

Supporting Documents:

Pharmaceutical product Recall Esmya (Ulipristal acetate) 5mg Tablet.pdf:

View Document

Recall one Batch of pharmaceutical product Dopamine HCL 200mg5ml ampoule.pdf:

View Document

Fraudulent Coronavirus tests, Vaccines _ Treatments Teas, essential oils, tinctures and colloidal silver.pdf:

View Document

Medical Device Alerts Anesthesia devices.pdf:

View Document

Recall, Suspension of registration and stop Importation of all Ranitidine drugs.pdf:

View Document